Please login to the form below

Not currently logged in


This page shows the latest satralizumab news and features for those working in and with pharma, biotech and healthcare.

Roche’s Soliris rival Enspryng bags FDA approval

Roche’s Soliris rival Enspryng bags FDA approval

Enspryng ( satralizumab) has been approved to treat adult patients living with anti-aquaporin-4 (AQP4) antibody positive NMOSD, a rare autoimmune disorder of the central nervous system which is often misdiagnosed

Latest news

More from news
Approximately 4 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company

ROAD is a digital PR and communications consultancy specialising in promoting the innovators that shape our future health and wellbeing....

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...